Post Market Clinical Follow Up Study for ReliaTack™ Articulating Reloadable Fixation Device With Deep Purchase Tacks

Exclusion Criteria

• •1. Institutional Review Board (IRB) consent requirement cannot be met:
• •1. waiver of subject informed consent requirements are not granted by IRB\* and,
• •2. an altercation to the consent process is not granted by the IRB and,
• •3. subject or subject's parent or legal guardian is unable or unwilling to provide signed informed consent
• •2. Subject was participating in any investigational drug or device study at the time of surgery or within 30-day (+3 days) study window
• •3. Subject was pregnant at the time of procedure
• •4. Subject had a documented allergy at the time of surgery to any of the components of the device or the mesh implant
• •5. Subject was treated with any other implantable mechanical fixation device, other than sutures
• •* A waiver of subject informed consent procedures will be requested from all IRBs of record for this study.